Radiation-induced craniofacial bone growth inhibition: Efficacy of cytoprotection following a fractionated dose regimen

Plastic and Reconstructive Surgery

Volumn 115, Issue 7, 2005, Pages 1973-1985

  La Scala, Giorgio C ^a   O'Donovan, David A ^a   Yeung, Ivan ^a   Darko, Johnson ^a   Addison, Patrick D ^a   Neligan, Peter C ^a   Pang, Cho Y ^a   Forrest, Christopher R ^a,b  

^a Hospital for Sick Children ^*

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE DISEASE; BONE GROWTH; BONE MATURATION; BONE RADIOGRAPHY; BONE SCINTISCANNING; CELL PROTECTION; CEPHALOMETRY; CONTROLLED STUDY; CRANIOFACIAL BONE GROWTH INHIBITION; CRANIOFACIAL DEVELOPMENT; DRUG EFFICACY; HEAD AND NECK CANCER; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RADIATION DOSE FRACTIONATION; ZYGOMA;

EID: 20044381121     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000163322.22436.3B     Document Type: Article

References (49)

1. Röntgen, W. C. Ueber eine neue Art von Strahlen. Leipzig: J. A. Barth, 1898.
2. Hall, E. J. Milestones in the radiation sciences. In E. J. Hall (Ed.), Radiobiology for the Radiologist, 5th Ed. Philadelphia: Lippincott Williams & Wilkins, 2000. Pp. 1-4.
3. Perthes, G. Ueber den Einfluss der Röntgenstrahlen auf epitheliale Gewebe, insbesondere auf das Carcinom. Langenbecks Arch. Klin. Chir. 71: 955, 1903.
4. Belkacemi, Y., Rio, B., and Touboul, E. Irradiation corporelle totale: Techniques, dosimétrie et complications. Cancer Radiother. 3: 162, 1999.
5. Guyuron, B., Dagys, A. P., and Munro, I. R. Long-term effects of orbital irradiation. Head Neck Surg. 10:85, 1987.
6. Guyuron, B., Dagys, A. P., Munro, I. R., and Ross, R. B. Effect of irradiation on facial growth: A 7- to 25-year follow-up. Ann. Plast. Surg. 11: 423, 1983.
7. Fromm, M., Littman, P., Raney, R. B., et al. Late effects after treatment of twenty children with soft tissue sarcomas of the head and neck: Experience at a single institution with a review of the literature. Cancer 57: 2070, 1986.
8. Cohen, S. R., Bartlett, S. P., and Whitaker, L. A. Reconstruction of late craniofacial deformities after irradiation of the head and face during childhood. Plast. Reconstr. Surg. 86: 229, 1990.
9. Goldwein, J. W., and Meadows, A. T. Influence of radiation on growth in pediatric patients. Clin. Plast. Surg. 20: 455, 1993.
10. Amendola, B. E., Lamm, F. R., Markoe, A. M., et al. Radiotherapy of retinoblastoma: A review of 63 children treated with different irradiation techniques. Cancer 66: 21, 1990.
11. Imhof, S. M., Mounts, M. P., Hofman, P., et al. Quantification of orbital and mid-facial growth retardation after megavoltage external beam irradiation in children with retinoblastoma. Ophthalmology 103: 263, 1996.
12. Jaffe, N., Toth, B. B., Hoar, R. E., Ried, H. L., Sullivan, M. P., and McNeese, M. D. Dental and maxillofacial abnormalities in long-term survivors of childhood cancer: Effects of treatment with chemotherapy and radiation to the head and neck. Pediatrics 73: 816, 1984.
13. Jackson, I. T., Carls, F., Bush, K., et al. Assessment and treatment of facial deformity resulting from radiation to the orbital area in childhood. Plast. Reconstr. Surg. 98: 1169, 1996.
14. Meadows, A. T., and Silber, J. Delayed consequences of therapy for childhood cancer. CA Cancer J. Clin. 35: 271, 1985.
15. Posnick, J. C., Policy, J. W., Zuker, R. M., and Chan, H. S. Chemotherapy and surgical resection combined with immediate reconstruction in a 1-year-old child with rhabdomyosarcoma of the maxilla. Plast. Reconstr. Surg. 89: 320, 1992.
16. Ju, D. M. C., Moss, M., and Crikelair, G. F. Effect of radiation on the development of facial structures in retinoblastoma cases. Am. J. Surg. 106: 807, 1963.
17. Goldwein, J. W. Effects of radiation therapy on skeletal growth in childhood. Clin. Orthop. Relat. Res. 262: 101, 1991.
18. O'Donovan, D. A., Yeung, I., Zeman, V., Neligan, P. C., Pang, C. Y., and Forrest, C. R. Radiation-induced craniofacial bone growth inhibition: Development of an animal model. J. Craniofac. Surg. 12: 533, 2001.
19. Capizzi, R. L. Clinical status and optimal use of amifostine. Oncology (Huntingt.) 13: 47, 1999.
20. Capizzi, R. L. Protection of normal tissues from the cytotoxic effects of chemotherapy by amifostine (Ethyol): Clinical experiences. Semin. Oncol. 21: 8, 1994.
21. Wasserman, T. H. Radiotherapeutic studies with amifostine (Ethyol). Semin. Oncol. 21: 21, 1994.
22. McCulloch, W., Scheffler, B. J., and Schein, P. S. New protective agents for bone marrow in cancer therapy. Cancer Invest. 9: 279, 1991.
23. Curran, W. J. Radiation-induced toxicities: The role of radioprotectants. Semin. Radiat. Oncol. 8: 2, 1998.
24. Dorr, R. T. Radioprotectants: Pharmacology and clinical applications of amifostine. Semin. Radiat. Oncol. 8: 10, 1998.
25. Mehta, M. P. Protection of normal tissues from the cytotoxic effects of radiation therapy: Focus on amifostine. Semin. Radiat. Oncol. 8: 14, 1998.
26. Delaney, J. P., Bonsack, M. E., and Felemovicius, I. Radioprotection of the rat small intestine with topical WR-2721. Cancer 74: 2379, 1994.
27. Rudat, V., Meyer, J., Momm, F., et al. Protective effect of amifostine on dental health after radiotherapy of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 48: 1339, 2000.
28. Forrest, C. R., O'Donovan, D. A., Yeung, I., et al. Efficacy of radioprotection in the prevention of radiation-induced craniofacial bone growth inhibition. Plast. Reconstr. Surg. 109: 1311, 2002.
29. Hall, E. J. Time, dose, and fractionation in radiotherapy. In E. J. Hall, (Ed.), Radiobiology for the Radiologist, 5th Ed. Philadelphia: Lippincott Williams & Wilkins, 2000. Pp. 397-418.
30. Wong, L., Richtsmeier, J. T., and Manson, P. N. Craniofacial growth following rigid fixation: Suture excision, miniplating, and microplating. J. Craniofac. Surg. 4: 234, 1993.
31. Genant, H. K., and Boyd, D. Quantitative bone mineral analysis using dual energy computed tomography. Invest. Radiol. 12: 545, 1977.
32. Montgomery, D. C. Design and Analysis of Experiments, 5th Ed. New York: John Wiley, 2001.
33. Takahashi, S., Sugimoto, M., Kotoura, Y., Sasai, K., Oka, M., and Yamamuro, T. Long-term changes in the haversian systems following high-dose irradiation. An ultrastructural and quantitative histomorphological study. J. Bone Joint Surg. (Am.) 76: 722, 1994.
34. Hinkel, C. L. Effect of roentgen rays upon growing long bones of albino rats: Quantitative studies of growth limitation following irradiation. Am. J. Roentgenol. 47: 439, 1942.
35. Barr, J. S., Lingley, J. R., and Gall, E. A. Effect of roentgen irradiation on epiphyseal growth: I. Experimental studies upon the albino rat. Am. J. Roentgenol. 49: 104, 1943.
36. Jacobsson, M. G., Jonsson, A. K., Albrektsson, T. O., and Turesson, I. E. Short- and long-term effects of irradiation on bone regeneration. Plast. Reconstr. Surg. 76: 841, 1985.
37. Jacobsson, M., Albrektsson, T., and Turesson, I. Dynamics of irradiation injury to bone tissue: A vital microscopic investigation. Acta Radiol. Oncol. 24: 343, 1985.
38. Jacobsson, M., Kalebo, P., Albrektsson, T., and Turesson, I. Provoked repetitive healing of mature bone tissue following irradiation: A quantitative investigation. Acta Radiol. Oncol. 25: 57, 1986.
39. Cormack, D. H. Introduction to Histology. Philadelphia: J. B. Lippincott, 1984. Pp. 164-198.
40. Yuhas, J. M., Spellman, J. M., and Culo, F. The role of WR-2721 in radiotherapy and/or chemotherapy. Cancer Clin. Trials 3: 211, 1980.
41. Patt, H. M., Tyree, E. B., Straube, R. L., and Smith, D. E. Cysteine protection against X-irradiation. Science 110: 213, 1949.
42. Grdina, D. J., Kataoka, Y., and Murley, J. S. Amifostine: Mechanisms of action underlying cytoprotection and chemoprevention. Drug Metabol. Drug Interact. 16: 237, 2000.
43. Shaw, L. M., Glover, D., Turrisi, A., et al. Pharmacokinetics of WR-2721. Pharmacol. Ther. 39: 195, 1988.
44. Brown, P. E. Mechanism of action of aminothiol radio-protectors. Nature 213: 363, 1967.
45. Grdina, D. J., Constantinou, A., Shigematsu, N., and Murley, J. S. Inhibition of topoisomerase II alpha activity in CHO K1 cells by 2-[(aminopropyl)amino]ethanethiol (WR-1065). Radiat. Res. 138: 44, 1994.
46. Capizzi, R. L., and Oster, W. Chemoprotective and radioprotective effects of amifostine: An update of clinical trials. Int. J. Hematol. 72: 425, 2000.
47. Yuhas, J. M. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)- ethylphosphorothioic acid. Cancer Res. 40: 1519, 1980.
48. Hensley, M. L., Schuchter, L. M., Lindley, C., et al. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J. Clin. Oncol. 17: 3333, 1999.
49. Tannehill, S. P., and Mehta, M. P. Amifostine and radiation therapy: Past, present, and future. Semin. Oncol. 23: 69, 1996.